Review
Protean Manifestations of Vitamin D Deficiency, Part 3: Association with Cardiovascular Disease and Disorders of the Central and Peripheral Nervous Systems
Abstract
Vitamin D deficiency is associated with the risk factors of inflammation, insulin resistance and endothelial dysfunction, and left ventricular hypertrophy. As a result there is an increase in cardiovascular events (CVEs) associated with vitamin D deficiency. Vitamin D deficiency itself or secondary hyperparathyroidism or both may be responsible for the increase in CVEs. Correction of vitamin D deficiency may decrease the incidence of CVEs. Vitamin D deficiency is also associated with Alzheimer disease, schizophrenia, depression, and chronic pain and muscle weakness. Vitamin D deficiency is early treated with oral vitamin D supplements which may improve the manifestations of the diseases associated with vitamin D deficiency.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008;52:1949-1956.
2. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010;55:1283-1288.
3. Walker MD, Fleischer J, Rundek T, et al. Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab 2009;94:3849-3856.
4. Kendrick J, Targher G, Smits G, et al. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey.Atherosclerosis 2009;205:255-260.
5. Ginde AA, Scragg R, Schwartz RS, et al. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009;57:1595-1603.
6. Ngo DT, Sverdlov AL, McNeil JJ, et al. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am J Med 2010;123:335-341.
7. Hjelmesaeth J, Hofs D, Aasheim ET, et al. Parathyroid hormone, but not vitamin D, is associated with metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol 2009;8:7.
8. Krause R, Bühring M, Hopfenmüller W, et al. Ultraviolet B and blood pressure. Lancet 1998;352:709-710.
9. Sugden JA, Davies JI, Witham MD, et al. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008;25:320-325.
10. Witham MD, Dove FJ, Dryburgh M, et al. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010;53:2112-2119.
11. Shea MK, Benjamin EJ, Dupuis J, et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr 2009;63:458-464.
12. Kazlauskaite R, Powell LH, Mandupakala C, et al. Vitamin D is associated with atheroprotective high-density lipoprotein profile in post-menopausal women. J Clin Lipidol 2010;4:113-119.
13. Oh J, Weng S, Felton SK, et al. 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687-698.
14. Walker MD, Fleischer J, Rundek T, et al. Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab 2009;94:3849-3856.
15. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-511.
16. Blair TM. Paper presented at the American College of Cardiology meeting; Atlanta, GA; March 16, 2010.
17. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiograph. J Clin Endocrinol Metab 2008;93:3927-3935.
18. Liu L. Serum 25-hydroxy vitamin D concentration: heart failure mortality and premature death from all causes in US adults: an eight year follow-up study. Heart Failure Society of America. 2010. Abstract 018.
19. Boxer RS, Dauser DA, Walsh SJ, et al. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 2008;56:454-461.
20. Pilz S, Tomaschitz A, Ritz E, et alMedscape. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009;6:621-630.
21. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-238.
22. Nemerovski CW, Dorsch MP, Simpson RU, et al. Vitamin D and cardiovascular disease. Pharmacotherapy 2009;2:691-708.
23. Rostand SG, Drüeke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999;56:383-392.
24. Wu J, Garami M, Cheng T, et al. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 1996;97:1577-1588.
25. Walker MD, Fleischer JB, Di Tullio MR, et al. Cardiac structure and diastolic function in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2010;95:2172-2179.
26. Atif F, Sayeed I, Ishrat T, et al. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol Med 2009;15:328-336.
27. Wilkins CH, Sheline YI, Roe CM, et al. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006;14:1032-1040.
28. Oudshoorn C, Mattace-Raso FU, van der Velde N, et al. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008;25:539-543.
29. Lee DM, Tajar A, Ulubaev A, et al; EMAS Study Group. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 2009;80:722-729.
30. Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010;170:1135-1141.
31. Schneiders J. Paper presented at European Society for Endocrinology meeting; Prague; April 25, 2010 [abstract 559].
32. Knekt P, Kilkkinen A, Rissanen H, et al. Serum vitamin D and the risk of Parkinson disease. Arch Neurol 2010;67:808-811.
33. Evatt ML. Beyond vitamin status: is there a role for vitamin D in Parkinson disease? Arch Neurol 2010;67:795-797.
34. Hoogendijk WJ, Lips P, Dik MG, et al. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008;65:508-512.
35. Hicks GE, Shardell M, Miller RR. Association between vitamin D status and pain in older adults: the Invecchiare in Chianti study. J Am Geriatr Soc 2008;56:785-791.
36. Kinney DK, Teixeira P, Hsu D, et al. Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections?Schizophr Bull 2009;35:582-595.
37. McGrath J, Saari K, Hakko H, et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 2004;67:237-245.
38. Prabhala A, Garg R, Dandona P. Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med 2000;160:1199-1203.
39. Roesel TR. Vitamin D deficiency in Iraq and Afghanistan veterans with chronic musculoskeletal pain.J Occup Environ Med 2008;50:613-614.
40. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003;78:1463-1470.
41. Block SR. Vitamin D deficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. Mayo Clin Proc 2004;79:1585-1586; author reply 1586-1587.
42. Mascarenhas R, Mobarhan S. Hypovitaminosis D-induced pain. Nutr Rev 2004;62:354-359.
43. Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 2008;168:771-772.
44. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999-2006.
45. Chaganti RK, Parimi N, Cawthon P, et al. Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the osteoporotic fractures in men study. Arthritis Rheum2010;62:511-514.
46. Bell DS. Resolution of statin-induced myalgias by correcting vitamin D deficiency. South Med J 2010;103:690-692.
47. Ahmed W, Khan N, Glueck CJ, et al. Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 2009;153:11-16.
48. Lee P, Greenfield JR, Campbell LV. Vitamin D insufficiency-a novel mechanism of statin-induced myalgia? Clin Endocrinol (Oxf) 2009;71:154-155.
49. Bittner V. Paper presented at the American College of Cardiology meeting; Atlanta, GA; March 15, 2010.
50. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008;52:1949-1956.
51. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281.
